EPISCREEN
LIVE

Serial Number

86716415

Owner

Polytherics Limited

Attorney

Joyce von Natzmer

Filing Date

Aug 6, 2015

Add to watchlist:

No watchlists yet
View on USPTO

EPISCREEN Trademark

Serial Number: 86716415 • Registration: 5093688

EPISCREEN is a trademark filed by Polytherics Limited on August 6, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Polytherics Limited (8 trademarks)

The London Bioscience Innovation Centre
Camden, London NW10NH , GB

Entity Type: 11

ABZENA (UK) LIMITED (9 trademarks)

900 BABRAHAM RESEARCH CAMPUS, BABRAHAM
CAMBRIDGE CB22 3AT , GB

Entity Type: 24

Trademark Details

Filing Date

August 6, 2015

Registration Date

December 6, 2016

Published for Opposition

June 28, 2016

Goods & Services

Medical services, namely, providing medical information regarding pharmaceuticals; Pharmacy and health advice; pharmaceutical services and provision of pharmaceutical information, all in the nature of providing medical information regarding pharmaceuticals; Medical screening; Medical screening to assess the potential immunogenicity of therapeutic antibodies and proteins

[ Pharmaceuticals and pharmaceutical preparations used to treat cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemical preparations for medical or pharmaceutical purposes, namely, chemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; vaccines; pharmaceutical preparations for skin care ]

Scientific research and product development services in relation to pharmaceutical and medical products; pharmaceutical research services; pharmaceutical product evaluation; testing of pharmaceuticals, namely, assessing the potential immunogenicity of proteins and antibodies by measuring immune cell responses to the pharmaceutical; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information in the fields of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; toxicology services; provision of scientific information relating to the chemical industry, namely, information on the subject of chemical product development

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 6, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sep 30, 2023 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Sep 30, 2023 8.PR
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sep 22, 2023 EROP
POST REGISTRATION ACTION MAILED - SEC. 8
Jun 2, 2023 PRA8
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 2, 2023 APRE
TEAS SECTION 8 RECEIVED
Dec 2, 2022 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 6, 2021 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 31, 2019 ASGN
REGISTERED-PRINCIPAL REGISTER
Dec 6, 2016 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 31, 2016 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 30, 2016 AITU
NOTICE OF ALLOWANCE CANCELLED
Oct 11, 2016 IUCN
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 11, 2016 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 23, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 20, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 13, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2016 CRFA
ASSIGNED TO LIE
Apr 28, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 19, 2015 GNRN
NON-FINAL ACTION E-MAILED
Nov 19, 2015 GNRT
NON-FINAL ACTION WRITTEN
Nov 19, 2015 CNRT
ASSIGNED TO EXAMINER
Nov 18, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2015 NWOS
NEW APPLICATION ENTERED
Aug 10, 2015 NWAP